Effects of Landscapes on the Brain

July 9, 2021 updated by: Agnieszka Olszewska-Guizzo, National University of Singapore

Effects of Landscapes on the Brain: Assessment of Neurophysiological Response in Healthy and Depressed Individuals to Different Landscape Quality Exposures in Singapore

There is an established consensus between researchers that the contact with natural environments has beneficial influence on mental health and well-being of people exposed to them. The knowledge in this area is based mostly on the correlational analyses, but more research is needed to explore the causal relationships between the human and his environment. More specifically, in order to identify specific restorative mechanisms in response to the specific types and components of the designed landscapes, especially in the highly urbanized context.

This study will attempt to find the psychophysiological responses in human brain to landscapes videos (in the lab), and real landscapes with different visual quality, carefully pre-selected and analysed in terms of landscape composition. In the study the rigorous experimental protocol will be administered in order to acquire qualitative and quantitative data both self-reported and measured by neuroscience tools, in order to demonstrate the causal effect of landscape exposure on the brain activity patterns and mood of healthy and depressed individuals.

Study Overview

Status

Completed

Detailed Description

Understanding of the impact of urban green landscapes with different design and levels of contemplativeness on brain function may pave the way to more scientifically informed and more healthy planning and design of urban living environment.

Also the exposure to certain types of landscapes may be useful in mental health promotion and support for the existing treatments in patients with depression.

Specific aims The aim of the study is to assess the effects of passive exposure (viewing) images of differently designed landscapes on the brain activity of two groups: 1) healthy individuals and 2) patients with depression, using electroencephalography (EEG) and Functional Near-Infrared Spectroscopy (fNIRS). The investigators also want to compare effects of exposure to images with the in-situ immersion with the real environment.

Following the assumption that there are certain types and components of the living environments that influence our mental health and well-being even if one is passively exposed to them, the investigators want to to assess the effects of passive exposure to three differently designed, representative landscapes on the brain activity of healthy individuals. And to compare effects of exposure to images with the in-situ immersion with the real environment.

Hypothesis The investigators hypothesise that landscapes, that the Therapeutic Garden, which also achieved a high score in the Contemplative Landscape expert evaluation scale, will induce the brain activity patterns commonly associated with the relaxation, and bottom-up attention, unlike the other selected sites with lower scores. Additionally, the investigators hypothesize that in the real landscape exposures they will observe this phenomenon more intensely than in the case of images exposure.

PARTICIPANTS The investigators will recruit 100 right-handed healthy participants aged 21-75 y.o. Based on previous studies using fNIRS to study motor task (Siedel et al., 2017), the minimum number of participants is 50 participants per group. As a result, recruitment of 100 participants in order to ensure the minimal number of participants in the case of dropouts was proposed.

Exclusion criteria:

  • Left-handedness;
  • serious visual impairment; reported psychiatric, neurological or cognitive diseases;
  • reported use of medication that could alter the functioning of the Central Nervous System at the time of the experiment;
  • existence of a pacemaker, intracranial electrodes, implanted defibrillator or plates,
  • otologic surgery in the last 12 months.

The investigators will also recruit 100 right-handed patients with diagnosed depression at the Neuroscience Clinic or Psychiatric ward in National University Hospital (NUH)

Inclusion criteria:

  • Age of 21 to 75
  • Right-handed only
  • They must suffer from depressive disorder,

Exclusion criteria:

  • Major neurological disorders e.g. epilepsy, stroke
  • Any form of cancer
  • Major heart diseases: e.g. ischemic heart disease
  • Major lung diseases: e.g. chronic obstructive pulmonary disorder.
  • Major liver disease e.g. liver failure
  • Major kidney disease e.g. kidney failure.

Recruitment:

The target individuals will be recruited by word of mouth. The principal investigator or co-investigator will approach the participants who fulfil the inclusion criteria and explain the purpose and procedure of this project. If the participant agrees to participate in this project, he or she will sign the consent form after reading the Participant Information Sheet that provides information about this study. Then the investigators will arrange the time schedule to perform the sessions for the participant.

Ethics approvals:

For healthy participants: Ref #: S-18-352 For patients: NHG DSRB Ref # 2018/01036

METHODS NEUROIMAGING EQUIPMENT The NIRS and EEG data will be collected using NIRSport (LLC NIRx Medical Technologies). The former consists of 8 illumination sources and 8 detection sensors with two wavelengths of 760nm & 850nm, yields 128 data channels, with a sampling rate 62.5 Hz.

The latter is V-Amp 16-channel portable EEG system, with active -dry type of electrodes (actiCAP Xpress), bandwidth of 0Hz (DC) - 500Hz(-3 dB) and sampling rate up to 20.000 Hz. Both devices are lightweight, portable and adjusted to the outdoor environment data collection, and mountable on one single cap to reduce discomforts of long data collection for participants.

EXPERIMENTAL DESIGN

This study is a non-randomised within subjects clinical trial. All participants will attend four landscape viewing sessions while having their brains imaged using the fNIRS and EEG (both machines combined into 1 cap), they will also complete an emotional state assessment questionnaire (Profile of Mood States - POMS, [Shacham,1983]), landscape preference questionnaire (Self-Assessment Manikin) and Beck Depression Inventory (BDI).The latter will serve as a control for the extreme scores in the healthy population i.e. if a healthy patricipants score shows that this participant may suffer from undiagnosed depression their data may be eliminated from the further analysis. The participant with high depression score will be advised to seek clinical assessment by psychiatrist. First session will take place in the research room at the BIGHEART premises (lab indoor environment), and three remaining sessions in the 3 oudoor preselected sites (real landscapes) - see Table 1.

Table 1. Location of the data collection sessions, and estimated time of participation Viewing session Site Adress Estimated Time

  1. Lab (indoors) BIGHEART, 14 Medical Drive, #14-01. 50min
  2. Site 01 (outdoors) Therapeutic Garden @Hortpark, 33 Hyderabad Rd, Singapore 20min
  3. Site 02 (outdoors) Casa Clementi, Clementi Ave 1, Singapore 20min
  4. Site 03 (outdoors) Sheltered sidewalk, 32 New Market Rd, Singapore 20min

Indoor Experimental protocol The first, lab-based session will start with informed consent, and completion of pre-experiment POMS (profile of mood state) questionnaire. The participant code will be then attributed to each participant, their personal information will not be used any more in the study: they will not be needed in the future and will not need to be stored. All electronic devices in the room are to be switched off except necessary data collection equipment. The room temperature and humidity will be kept the same across all participants and conditions. Before the data collection each participant will have the multimodal NIRS and EEG device positioned on their heads.

Participants will be instructed to sit comfortably on a chair and without talking or moving calmly observe the landscape views displayed in front of them, while simultaneously their brain signals will be recorded using NIRS and EEG. Resting state activity for each participant will be recorded preceding the display of the videos.

There will be 1 minute of resting state (baseline) recording followed by the landscape 9 fixed-frame videos viewing, displayed for 20 seconds, repeated 3 times each in a randomized order to avoid order bias. In between the landscapes there will be a fixation cross displayed for 5 seconds. So the overall time of recording EEG/fNIRS signal will take about 13 minutes.

After that four questionnaires will be completed by the participant, including respectively: (1) post-experimental POMS questionnaire, (2) landscape preference questionnaire, (3) Depression scale (BDI questionnaire) and (4) socio-demographic questionnaire. There are some questions that may be deemed sensitive to some participants, in this case they are allowed to skip an uncomfortable question.

The whole procedure (including explanation, consent taking, questionnaire and cognitive tasks) should be completed within 50 min. The fNIRS and EEG signals recorded during landscapes viewing as well as each cognitive task will be stored in the computer.

Outdoor Landscape Experiment multimodal NIRS and EEG In this study participants will be invited to the site session, morning (between 10AM and 12PM) or afternoon (between 2PM and 4PM). For the safety of participants and sound quality of the study design the weather during the session must be normalized: not too hot, dry with clear or partly cloudy sky. In the event of the bad weather conditions (rain, storm, heat wave) the sessions will be postponed. The travel expenses for a participant getting to the sites will be included in the reimbursement.

Because of possibility of disruption of the public space (especially in the case of Site 03), only up to 2 participants can have the session scheduled at the same time.

After completing the pre-experimental POMS questionnaire, participants will be seated in front of an actual landscape view, and advised to calmly observe it, without moving. The researchers will control for the outdoor brightness using the standard light-meter, thus the onsite data collection should be performed at the similar time of a day, with the similar weather conditions and keeping all other factors (such as other visitors and any other distracting phenomena) at the similar levels across all participants.

All the rest of the outdoors experimental procedures will be similar to the laboratory procedure except no consent (the consent signing will take place prior to the outdoors sessions), no socio-demographic and no BDI questionnaire will be performed. Participants will be seated in front of each of 3 landscape views at a location, and for the baseline recording the white glasses will be put on their eyes to cover the view. After baseline recording they will passively watch the landscape view for 1 minutes.

After data collection the devices will be dismounted from the head of participant and the POMS questionnaire will be performed.

The time of the participation in the outdoor session will be therefore shorter, estimated at 20 minutes.

Study Type

Interventional

Enrollment (Actual)

95

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Singapore, Singapore, 117599
        • Institute for Health Innovation & Technology (iHealthtech)

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age of 21 to 75
  • Right-handed only
  • (They must suffer from depressive disorder)

Exclusion Criteria:

  • Major neurological disorders e.g. epilepsy, stroke
  • Any form of cancer
  • Major heart diseases: e.g. ischemic heart disease
  • Major lung diseases: e.g. chronic obstructive pulmonary disorder.
  • Major liver disease e.g. liver failure
  • Major kidney disease e.g. kidney failure.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Sequence of Landscape exposures
All participants undergo the procedure of visiting all landscape exposures in a random order.
landscapes classified as contemplative (through a CLM psychometric measure) are expected to elicit different brainwave oscillations as compared to non-contemplative ones.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
EEG power in alpha band
Time Frame: 5 minutes
predictor of positive affect and positive mental health outcomes, measured with EEG
5 minutes
EEG power in beta band
Time Frame: 5 minutes
more beta in the right temporal lobes associated with stimuli-driven attention, measured with EEG
5 minutes
fNIRS haemodynamics
Time Frame: 5 minutes
decreased oxy-hemoglobin in the frontal part of the brain indicates more relaxation
5 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Profile of mood states
Time Frame: 30 minutes
self-reported, pre-and post- stimulation Profile of Mood States (POMS) scale measures the change in the momentary mood, giving as an outcome measure the Total Mood Disturbance (TMD), where 1 is neutral, and above 1 is disturbed mood.
30 minutes
landscape preference measured with self-assessment manikin scale.
Time Frame: 30 minutes
measured using pictorial Self-Asessment Manikin (SAM) where score ranged from -3 to +3, where the lower the score the less positive (valence + arousal) emotions are caused by looking at the view
30 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 28, 2019

Primary Completion (Actual)

July 9, 2021

Study Completion (Actual)

July 9, 2021

Study Registration Dates

First Submitted

December 19, 2019

First Submitted That Met QC Criteria

December 22, 2019

First Posted (Actual)

December 26, 2019

Study Record Updates

Last Update Posted (Actual)

July 12, 2021

Last Update Submitted That Met QC Criteria

July 9, 2021

Last Verified

July 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • R-722-000-010-490

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Depression

Clinical Trials on Contemplative landscape exposure

Subscribe